Atlas FDA

Juvederm Voluma XC, Juvederm Vollure XC, and Juvederm Volbella XC

FDA premarket approval P110033/S033 · decided 2018-01-04

Approval details

PMA number
P110033
Supplement
S033
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Juvederm Voluma XC, Juvederm Vollure XC, and Juvederm Volbella XC
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2017-08-21
Decision date
2018-01-04
Days to decision
136 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
Approval for implementation of a scaled-up manufacturing process for the Juvederm Voluma XC, Juvederm Vollure XC, and Juvederm Volbella XC dermal fillers

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25